Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.74+0.07 (+0.19%)
At close: 4:00PM EDT
37.74 0.00 (0.00%)
After hours: 04:46PM EDT
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
2,238,532
2,122,353
1,814,254
1,794,894
1,597,930
Operating Expense
439,662
526,954
-808,922
430,448
658,238
Operating Income
1,798,870
1,595,399
2,623,176
1,364,446
939,692
Net Non Operating Interest Income Expense
-90,695
-128,680
-246,244
-255,515
-240,577
Other Income Expense
248,441
235,235
84,487
408,924
644,065
Pretax Income
1,956,616
1,701,954
2,461,419
1,517,855
1,343,180
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
971,621
495,198
1,187,270
1,377,729
1,210,025
Diluted NI Available to Com Stockholders
971,621
495,198
1,187,270
1,377,729
1,210,025
Basic EPS
-
1.61
3.35
3.89
3.42
Diluted EPS
-
1.61
3.35
3.89
3.42
Basic Average Shares
-
607,111
354,176
354,176
354,176
Diluted Average Shares
-
607,111
354,176
354,176
354,176
Total Operating Income as Reported
1,798,870
1,595,399
2,623,176
1,364,446
939,692
Total Expenses
439,662
526,954
-808,922
430,448
658,238
Net Income from Continuing & Discontinued Operation
971,621
975,040
2,348,535
1,377,729
1,210,025
Normalized Income
735,980
751,443
2,231,924
960,264
728,121
Interest Income
53,432
28,379
22,329
24,441
6,762
Interest Expense
144,127
157,059
268,573
279,956
247,339
Net Interest Income
-90,695
-128,680
-246,244
-255,515
-240,577
EBIT
2,100,743
1,859,013
2,729,992
1,797,811
1,590,519
EBITDA
2,123,739
-
-
-
-
Reconciled Depreciation
22,996
23,058
23,924
33,267
33,267
Net Income from Continuing Operation Net Minority Interest
971,621
975,040
2,348,535
1,377,729
1,210,025
Total Unusual Items Excluding Goodwill
235,641
223,597
116,611
417,465
481,904
Total Unusual Items
235,641
223,597
116,611
417,465
481,904
Normalized EBITDA
1,888,098
1,658,474
2,637,305
1,413,613
1,141,882
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement